Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.
1970
1.1K+
LTM Revenue $228M
LTM EBITDA $37.0M
$269M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Lumibird has a last 12-month revenue of $228M and a last 12-month EBITDA of $37.0M.
In the most recent fiscal year, Lumibird achieved revenue of $222M and an EBITDA of $29.7M.
Lumibird expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Lumibird valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $209M | $222M | XXX | XXX | XXX |
Gross Profit | $115M | $130M | XXX | XXX | XXX |
Gross Margin | 55% | 59% | XXX | XXX | XXX |
EBITDA | $35.1M | $29.7M | XXX | XXX | XXX |
EBITDA Margin | 17% | 13% | XXX | XXX | XXX |
Net Profit | $14.9M | $12.2M | XXX | XXX | XXX |
Net Margin | 7% | 5% | XXX | XXX | XXX |
Net Debt | $8.3M | $46.2M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Lumibird's stock price is EUR 9 (or $10).
Lumibird has current market cap of EUR 204M (or $219M), and EV of EUR 250M (or $269M).
See Lumibird trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$269M | $219M | XXX | XXX | XXX | XXX | $0.36 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Lumibird has market cap of $219M and EV of $269M.
Lumibird's trades at 1.2x LTM EV/Revenue multiple, and 7.3x LTM EBITDA.
Analysts estimate Lumibird's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Lumibird and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $269M | XXX | XXX | XXX |
EV/Revenue | 1.2x | XXX | XXX | XXX |
EV/EBITDA | 9.1x | XXX | XXX | XXX |
P/E | 28.6x | XXX | XXX | XXX |
P/E/Growth | 0.5x | XXX | XXX | XXX |
EV/FCF | -51.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpLumibird's NTM/LTM revenue growth is 8%
Lumibird's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Lumibird's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Lumibird's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Lumibird and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 6% | XXX | XXX | XXX | XXX |
EBITDA Margin | 13% | XXX | XXX | XXX | XXX |
EBITDA Growth | -15% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 22% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 53% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
Clarity Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Cyclopharm | XXX | XXX | XXX | XXX | XXX | XXX |
Healius | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lumibird acquired XXX companies to date.
Last acquisition by Lumibird was XXXXXXXX, XXXXX XXXXX XXXXXX . Lumibird acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Lumibird founded? | Lumibird was founded in 1970. |
Where is Lumibird headquartered? | Lumibird is headquartered in France. |
How many employees does Lumibird have? | As of today, Lumibird has 1.1K+ employees. |
Who is the CEO of Lumibird? | Lumibird's CEO is Mr. Marc Le Flohic. |
Is Lumibird publicy listed? | Yes, Lumibird is a public company listed on PAR. |
What is the stock symbol of Lumibird? | Lumibird trades under LBIRD ticker. |
When did Lumibird go public? | Lumibird went public in 1997. |
Who are competitors of Lumibird? | Similar companies to Lumibird include e.g. Australian Clinical Labs, Clarity Pharmaceuticals, CurveBeam AI, Cyclopharm. |
What is the current market cap of Lumibird? | Lumibird's current market cap is $219M |
What is the current revenue of Lumibird? | Lumibird's last 12-month revenue is $228M. |
What is the current EBITDA of Lumibird? | Lumibird's last 12-month EBITDA is $37.0M. |
What is the current EV/Revenue multiple of Lumibird? | Current revenue multiple of Lumibird is 1.2x. |
What is the current EV/EBITDA multiple of Lumibird? | Current EBITDA multiple of Lumibird is 7.3x. |
What is the current revenue growth of Lumibird? | Lumibird revenue growth between 2023 and 2024 was 6%. |
Is Lumibird profitable? | Yes, Lumibird is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.